Literature DB >> 18689782

Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis.

G Benchekroun1, P de Fornel-Thibaud, S Lafarge, E Gomez, D Begon, F Delisle, R Moraillon, D Héripret, C Maurey, D Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18689782     DOI： 10.1136/vr.163.6.190

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  2 in total

1.  Animal models of adrenocortical tumorigenesis.

Authors:  Felix Beuschlein; Sara Galac; David B Wilson
Journal:  Mol Cell Endocrinol       Date:  2011-11-11       Impact factor: 4.102

2.  Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Authors:  C Arenas; C Melián; M D Pérez-Alenza
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.